Pharsight

Drugs that contain Itraconazole

1. Onmel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6509038 SEBELA IRELAND LTD Antifungal compositions with improved bioavailability
May, 2017

(6 years ago)

US7081255 SEBELA IRELAND LTD Antifungal compositions with improved bioavailability
May, 2017

(6 years ago)

US8591948 SEBELA IRELAND LTD Antifungal compositions with improved bioavailability
May, 2017

(6 years ago)

US8486456 SEBELA IRELAND LTD Itraconazole compositions with improved bioavailability
Oct, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Apr 29, 2013

Market Authorisation Date: 29 April, 2010

Treatment: Onychomycosis of the toenail caused by tricophyton rubrum or trichophyton mentagrophytes, once daily use for 12 consecutive weeks

Dosage: TABLET;ORAL

More Information on Dosage

ONMEL family patents

Family Patents

2. Sporanox patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5633015 JANSSEN PHARMS Beads having a core coated with an antifungal and a polymer
May, 2014

(9 years ago)

US5707975 JANSSEN PHARMS Oral formulations on an antifungal
Jan, 2015

(9 years ago)

US6407079 JANSSEN PHARMS Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
Jun, 2019

(4 years ago)

Market Authorisation Date: 11 September, 1992

Treatment: NA

Dosage: CAPSULE;ORAL; INJECTABLE;INJECTION

How can I launch a generic of SPORANOX before it's drug patent expiration?
More Information on Dosage

SPORANOX family patents

Family Patents

3. Tolsura patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8771739 MAYNE PHARMA Pharmaceutical compositions for poorly soluble drugs
Jul, 2023

(8 months ago)

US9272046 MAYNE PHARMA Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US10806792 MAYNE PHARMA Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US10463740 MAYNE PHARMA Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US8921374 MAYNE PHARMA Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US9713642 MAYNE PHARMA Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

Market Authorisation Date: 11 December, 2018

Treatment: Treatment of fungal infections, including blastomycosis, histoplasmosis, and aspergillosis

Dosage: CAPSULE;ORAL

More Information on Dosage

TOLSURA family patents

Family Patents